Meng Yuan

7PUBLICATIONS
7CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 19, 2023
Enhanced prediction of postoperative radiotherapy-induced esophagitis in non-small cell lung cancer: Dosiomic model development in a real-world cohort and validation in the PORT-C randomized controlled trial.

Zeliang Ma, Bin Liang, Ran Wei

|Oct 25, 2022
Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer.

Meng Yuan, Yirui Zhai, Yu Men

|Feb 14, 2022
Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer.

Meng Yuan, Yirui Zhai, Yu Men

|Dec 15, 2021
Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.

Yongxing Bao, Xu Yang, Yu Men

|Oct 22, 2021
Endostar (rh-endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis.

Meng Yuan, Yirui Zhai, Yu Men

|Mar 17, 2021
Risk of cardiac-related mortality in stage IIIA-N2 non-small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database.

Xin Sun, Yu Men, Jianyang Wang

Pageof 2

Frequent Collaborators

7 joint publications

Zhouguang Hui

3 joint publications

Lei Deng

3 joint publications

Shuang Sun

3 joint publications

Yongxing Bao